期刊文献+

β-catenin在胆管细胞癌中的表达特点及其临床意义

下载PDF
导出
摘要 目的探讨连环蛋白(beta-catenin)在胆管细胞癌中的表达特点及其临床意义。方法检测70例胆管细胞癌组织标本中beta-catenin的表达水平,并与患者临床、病理参数的相关性进行分析。结果Beta-catenin在正常胆管组织及癌旁组织阳性表达率分别为6.67%(1/15)、9.09%(3/33)。beta-catenin在胆管细胞癌中阳性表达率为57.14%,显著高于正常胆管组织和癌旁组织(P〈0.05)。胆管细胞癌分化程度越高,beta-catenin的阳性表达率越高,高分化组与低分化组比较差异有统计学意义(P〈0.05)。beta-catenin的表达与患者年龄和淋巴结转移有明显相关性,年龄越大患者阳性表达率越高,有淋巴结转移组与无淋巴结转移组比较差异有统计学意义(P〈0.05)。结论Beta-catenin的表达程度随肿瘤分化程度的增高而逐渐增强,beta-catenin可能参与肿瘤的浸润及转移,表达程度受年龄、有无淋巴结转移等病理参数影响。 Objective To explore the expression and significance of beta-catenin in cholangiocarcinoma. Methods To detect the expression of beta-eatenin in 70 cases of samples with cholangiocar cinoma. The relationship between beta-eatenin and clinical pathologic parameters was analyzed. Results The positive rate of beta-catenin in normal bile duct and adjacent tissues was 6.67% ( 1/15 ) and 9.09% ( 3/33 ) respectively. The positive rate of beta-catenin in cholangiocarcinoma was 57.14% and it was significantly higher than normal bile duct and adjacent tissues ( P〈0.05 ) .The positive rate increased with the developing process of cancer. The high differentiation was higher than poorly differentiated. The expression of beta-catenin had a significantly positive correlation with and clinical pathologic parameters ( P〈0.05 ) .The positive expression rate of beta-catenin was higher in older patients. The positive expression rate of lymph node metastasis group was significantly greater than the without group ( P〈0.05 ) . Conclusion The expression of beta - catenin increases with the developing of tumor differentiation. The beta-catenin may take part in the tumor invasion and metastasis. The expression of beta-catenin has correlation with the pathological parameters, such as age and lymph node metastasis.
出处 《浙江临床医学》 2015年第5期702-704,共3页 Zhejiang Clinical Medical Journal
基金 浙江省温州市科技局基金项目(Y20120043)
关键词 胆管细胞癌 连环蛋白 病理参数 Cholangiocarcinoma Beta-catenin Clinical pathologic parameters
  • 相关文献

参考文献10

二级参考文献53

  • 1霍钢,田加坤,唐文渊,郑履平,易勇.MMP-2及CD147在侵袭性垂体腺瘤中的表达及其相互关系的研究[J].中国神经精神疾病杂志,2005,31(3):168-171. 被引量:19
  • 2胡慧,薛新波,王从俊.甲状旁腺组织中细胞周期素D1过度表达与Rb肿瘤抑制基因的表达和临床意义[J].临床外科杂志,2006,14(4):224-225. 被引量:2
  • 3Nanashima A,Sumida Y,Abo T,et al.Relationship between pattern of tumor enhancement and clinicopathologic characteristics in intrahepatic cholangiocarcinoma.J Surg Oncol,2008,98:535-539. 被引量:1
  • 4Ohtsuka M,Ito H,Kimura F.Extended hepatic resection and outcomes in intrahepatic cholangiocarcinoma.J Hepatobiliary Pancreat Surg,2003,10:259-264. 被引量:1
  • 5Nakagohri T,Kinoshita T,Konishi M,et al.Surgical outcome and prognostic factors in intrahepatic cholangiocarcinoma.World J Surg,2008,32:2675-2680. 被引量:1
  • 6Gomez D,Morris-Stiff G,Toogood GJ,et al.Impact of systemic inflammation on outcome following resection for intrahepatic cholangiocarcinoma.J Surg Oncol,2008,97:513-518. 被引量:1
  • 7Nag S,DeHaan M,Scruggs G,et al.Long-term follow-up of patients of intrahepatic malignancies treated with iodine-125 brachytherapy.Int J Raadiat Oncol Biol Phys,2006,64:736-744. 被引量:1
  • 8Shimada M,Yamashita Y,Aishima S,et al.Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma.Br J Surg,2001,88:1463-1466. 被引量:1
  • 9Shirabe K,Shimada M,Harimoto N,et al.Intrahepatic cholangiocarcinoma:its mode of spreading and therapeutic modalities.Surgery,2002,131:S159-S164. 被引量:1
  • 10Kim YJ,Yun M,Lee WJ,et al.Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma.Eur J Nucl Med Mol Imaging,2003,30:1467-1472. 被引量:1

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部